Global pharmacy automation market was valued at $6.5 billion in 2025 and is growing at a CAGR of 8.0% during the forecast period (2026-2035). The rising demand for automated pharmacy solutions is being driven by the growing emphasis on value-based care, medication adherence, and improved therapy outcomes. Healthcare organizations are increasingly seeking systems that integrate clinical analytics, AI, and decision support to optimize medication management, reduce errors, and lower overall healthcare costs. These trends are directly contributing to the growth of the global pharmacy automation market, as automated solutions enable efficient dispensing, monitoring, and management of complex therapies across large patient populations.
Browse the full report description of “Pharmacy Automation Market Size, Share & Trends Analysis By Product (Automated Packaging And Labeling Systems, Automated Medication Dispensing Systems, Automated Storage And Retrieval Systems, Table Top Counters, and Others), By End User (Retail Pharmacy, Hospital Pharmacy, Inpatient Pharmacy Units, Outpatient Pharmacy Units, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/pharmacy-automation-market
AI and advanced analytics are increasingly applied not only in drug discovery however in medication management to improve adherence and patient outcomes. Strategic investments in value-based pharmacy solutions demonstrate the market’s push toward automated, data-driven care models that can efficiently manage large patient populations. Additionally, integration with clinical decision support and remote monitoring platforms enhances workflow efficiency, reduces errors, and supports cost containment factors central to the growing adoption of pharmacy automation globally.
For instance, in January 2026, Insilico Medicine and Servier formed a $888 million partnership to enhance the development of oncology therapies through AI-driven drug discovery. This multi-year collaboration allows Insilico to utilize its Pharma.AI platform to identify novel drug candidates for cancer while Servier brings its expertise in clinical development and regulatory strategy. The agreement includes up to $32 million in upfront research payments, with both companies sharing development costs. Insilico will focus on complex oncology targets, leveraging its AI capabilities alongside Servier's oncology pipeline and infrastructure. Insilico's current pipeline features candidates such as ISM6331 and ISM3412, both in Phase I clinical trials, along with four out-licensed oncology programs in early-stage studies.
Leading Companies Shaping the Pharmacy Automation Landscape
The pharmacy automation market is being driven by major players such as Becton Dickinson and Company (BD), Capsa Healthcare, Omnicell, Inc., McKesson Corp., and ScriptPro LLC. These companies are advancing digital health innovations, including telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, playing a pivotal role in the evolution of global healthcare delivery.
Market Coverage
Key questions addressed by the report.
Global Pharmacy Automation Market Report Segment
By Product
By End-User
Global Pharmacy Automation Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/pharmacy-automation-market